Update on Rimonabant—A Selective Cannabinoid CB1 Antagonist
Author:
Affiliation:
1. Xavier University 407 Bienville Street Natchitoches, Louisiana 71457
Publisher
SAGE Publications
Subject
Pharmacology (medical)
Link
http://journals.sagepub.com/doi/pdf/10.1345/aph.1G713
Reference3 articles.
1. Rimonabant—A Selective CB1 Antagonist
2. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study
3. Effects of Rimonabant on Metabolic Risk Factors in Overweight Patients with Dyslipidemia
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Identified synthesis and in-vivo study of oxidized metabolites of Rimonabant via LC–ESI–MS technique;Journal of Molecular Structure;2024-02
2. Use of Electrochemical Oxidation and Model Peptides To Study Nucleophilic Biological Targets of Reactive Metabolites: The Case of Rimonabant;Chemical Research in Toxicology;2014-09-26
3. Bioactivation of the Cannabinoid Receptor Antagonist Rimonabant to a Cytotoxic Iminium Ion Metabolite;Chemical Research in Toxicology;2012-12-12
4. Thromboangiitis Obliterans;Rutherford's Vascular Surgery;2010
5. Obesity and Renal Hemodynamics;Contributions to Nephrology;2006
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3